[Prospects of the use of neoplasm antigens as markers of gynecologic diseases].
CA-125 antigen was assayed in 108 patients with the most prevalent gynecologic diseases by enzyme immunoassay. Its blood levels were found to be under 35 U/ml in the patients with inflammatory diseases. In endometriosis and benign ovarian tumors CA-125 concentrations in the blood were elevated. Malignant tumors of the ovaries were detected in 80 percent of the examinees. CA-125 levels reduced after surgical treatment in 72 percent of patients. These data permit a conclusion that CA-125 diagnostic agent may be used to monitor the course of the postoperative period and assess the late results of treatment.
L V
LV
Adamian
N D
ND
Fanchenko
E N
EN
Andreeva
E A
EA
Novikov
M L
ML
Alekseeva
D000293:Adolescent; D000328:Adult; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000032:analysis*; D003937:Diagnosis, Differential; D004715:Endometriosis / Q000175:diagnosis / Q000276:immunology; D005260:Female; D005831:Genital Diseases, Female / Q000175:diagnosis* / Q000276:immunology; D006801:Humans; D007124:Immunoenzyme Techniques; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000175:diagnosis / Q000276:immunology; D011379:Prognosis; D014594:Uterine Neoplasms / Q000175:diagnosis / Q000276:immunology
D015295:Antigens, Tumor-Associated, Carbohydrate
Perspektivy primeneniia rakovykh antigenov v kachestve markerov ginekologicheskikh zabolevaniĭ.